GlassScriptPhysician profile
Kent Beam
NPI 1619437795
$4,495.66
in general payments reported to CMS, 2019-2025
7 companies · $4,358 in 2025
The $4,358 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $138 · 2025: $4,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $2,333 · Food and Beverage: $1,320 · Travel and Lodging: $622 · Education: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $2,333.33 |
| Food and Beverage | $1,319.50 |
| Travel and Lodging | $621.59 |
| Education | $221.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,811.03 | 2025 | Resolute Onyx, Corevalve Evolut R, Onyx Frontier |
| Boston Scientific Corporation | $1,199.18 | 2024-2025 | General - Therapies, General - Vascular Access, Sentinel |
| Abiomed | $254.42 | 2025 | |
| Angiodynamics, INC. | $125.44 | 2025 | Alphavac |
| Novo Nordisk INC | $50.00 | 2025 | Wegovy |
| Recor Medical INC | $34.77 | 2025 | Paradise Ultrasound Renal Denervation System |
| Biotronik INC. | $20.82 | 2024 | Acticor 7 Vr-T Dx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Beam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.